You are viewing the site in preview mode

Skip to main content

Advertisement

Table 4 Treatment success among study subgroups

From: Treatment outcomes from community-based drug resistant tuberculosis treatment programs: a systematic review and meta-analysis

Subgroups Studies Treatment success
  (n) (95% CI)
Year study began   
2002 or later 5 68% (59-75)
Before 2002 5 63% (52-73)
Patient’s age   
Included patients ≤14 years old 6 67% (54-78)
All patients >14 years old 4 65% (62-68)
HIV prevalence   
0-2% 4 72% (61-81)
HIV > 2% 2 85% (55-100)
Not specified or unknown 4 61% (46-75)
XDRTB prevalence   
0% 3 75% (55-91)
>0% 2 53% (26-78)
Not specified or unknown 5 67% (61-73)
Treatment model   
Individualized 6 65% (54-75)
Standardized 4 66% (60-71)
DOTS location   
Included home-based option 4 64% (61-68)
Clinic or public health centre only 4 63% (45-79)
Not specified 2 82% (54-98)
DOTS provider   
Family members, neighbours or household members sometimes utilized 3 62% (55-69)
Only CHWs, HCWs and other medical practitioners 7 66% (57-74)